Literature DB >> 3052105

Acute inhibition of rat heart protein synthesis in vitro during beta-adrenergic stimulation or hypoxia.

S J Fuller1, P H Sugden.   

Abstract

In the anterogradely perfused rat heart with glucose as fuel, 1 microM isoproterenol (ISO) inhibited the insulin (INS) plus adenosine deaminase (AdoDA) stimulation of ventricular protein synthesis by 72%. ISO (1 microM) alone had no effect on ventricular protein synthesis but inhibited atrial protein synthesis by 20%. The concentration dependence of the ISO inhibition was similar to the stimulation of glucose uptake by ISO. Inhibition could not be overcome by increasing INS concentrations. The effects of ISO were diminished by propranolol and could be partially mimicked by forskolin (FSK) or 8-(4-chlorophenylthio-)adenosine 3',5'-cyclic monophosphate (CPT-cAMP). The stimulation of protein synthesis by noncarbohydrate fuels was antagonized by ISO. Hypoxia (PO2 = 50%) also antagonized the INS stimulation of ventricular protein synthesis but did not affect basal rates. ATP contents were decreased by ISO but not by a PO2 of 50%. Both manipulations increased lactate output. The inhibition of protein synthesis by ISO could possibly be explained by indirect effects of ISO on cardiac "energy status." Furthermore, inhibition may thus represent purely an in vitro phenomenon and may not occur in vivo. However, the possibility that there are more direct effects of ISO on the machinery of protein synthesis has not been excluded. The inhibition of protein synthesis by hypoxia cannot be explained by changes in energy status and may result from intracellular lactoacidosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052105     DOI: 10.1152/ajpendo.1988.255.4.E537

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  The effects of the exogenous provision of lactate and the endogenous production of lactate on protein synthesis in the heart.

Authors:  S J Fuller; P H Sugden
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

Review 2.  Regulation of protein turnover in skeletal and cardiac muscle.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from adult rats. Stimulation of translation is mediated through the alpha 1-adrenoceptor.

Authors:  S J Fuller; C J Gaitanaki; P H Sugden
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

4.  Correlations between cardiac protein synthesis rates, intracellular pH and the concentrations of creatine metabolites.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

5.  Effects of increasing extracellular pH on protein synthesis and protein degradation in the perfused working rat heart.

Authors:  S J Fuller; C J Gaitanaki; P H Sugden
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

6.  Acute alpha 1-adrenergic stimulation of cardiac protein synthesis may involve increased intracellular pH and protein kinase activity.

Authors:  S J Fuller; C J Gaitanaki; R J Hatchett; P H Sugden
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

7.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

8.  Stimulation of cardiac protein synthesis by insulin-like growth factors.

Authors:  S J Fuller; J R Mynett; P H Sugden
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Low temperature acclimation decreases rates of protein synthesis in rainbow trout (Oncorhynchus mykiss) heart.

Authors:  D H Sephton; W R Driedzic
Journal:  Fish Physiol Biochem       Date:  1995-02       Impact factor: 2.794

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.